A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa ; volume:15 ; number:1 ; day:11 ; month:7 ; year:2024 ; pages:1-18 ; date:12.2024
Nature Communications ; 15, Heft 1 (11.7.2024), 1-18, 12.2024
- Urheber
-
Neumayer, Gernot
Torkelson, Jessica L.
Li, Shengdi
McCarthy, Kelly
Zhen, Hanson H.
Vangipuram, Madhuri
Mader, Marius M.
Gebeyehu, Gulilat
Jaouni, Taysir M.
Jacków-Malinowska, Joanna
Rami, Avina
Hansen, Corey
Guo, Zongyou
Gaddam, Sadhana
Tate, Keri M.
Pappalardo, Alberto
Li, Lingjie
Chow, Grace M.
Roy, Kevin R.
Nguyen, Thuylinh Michelle
Tanabe, Koji
McGrath, Patrick S.
Cramer, Amber
Bruckner, Anna
Bilousova, Ganna
Roop, Dennis
Tang, Jean Y.
Christiano, Angela
Steinmetz, Lars M.
Wernig, Marius
Oro, Anthony E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-49400-z
- URN
-
urn:nbn:de:101:1-2409282111182.708894680603
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Neumayer, Gernot
- Torkelson, Jessica L.
- Li, Shengdi
- McCarthy, Kelly
- Zhen, Hanson H.
- Vangipuram, Madhuri
- Mader, Marius M.
- Gebeyehu, Gulilat
- Jaouni, Taysir M.
- Jacków-Malinowska, Joanna
- Rami, Avina
- Hansen, Corey
- Guo, Zongyou
- Gaddam, Sadhana
- Tate, Keri M.
- Pappalardo, Alberto
- Li, Lingjie
- Chow, Grace M.
- Roy, Kevin R.
- Nguyen, Thuylinh Michelle
- Tanabe, Koji
- McGrath, Patrick S.
- Cramer, Amber
- Bruckner, Anna
- Bilousova, Ganna
- Roop, Dennis
- Tang, Jean Y.
- Christiano, Angela
- Steinmetz, Lars M.
- Wernig, Marius
- Oro, Anthony E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
STAT3 targeting in dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa - from biochemistry to interventions
Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa
Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
STAT3 targeting in dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa - from biochemistry to interventions
Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa
Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
STAT3 targeting in dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa - from biochemistry to interventions
Mesenchymal stromal cell therapy for dystrophic epidermolysis bullosa
Biomechanics and epidermal barrier disruption in dystrophic epidermolysis bullosa
Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)
Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa